share_log

Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.

Benzinga ·  Jan 2 21:17
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment